Close Menu
  • Home
  • Life Insurance
  • Auto Insurance
  • Home Insurance
  • Health Insurance
  • Business Insurance
  • Travel Insurance
  • Specialized Insurance
  • Insurance Tips & Guides
Facebook X (Twitter) Instagram
Insure GenZInsure GenZ Saturday, March 14
  • About Us
  • Contact Us
  • Disclaimer
  • Terms & Conditions
  • Privacy Policy
Facebook X (Twitter) Instagram
Subscribe
  • Home
  • Life Insurance
  • Auto Insurance
  • Home Insurance
  • Health Insurance
  • Business Insurance
  • Travel Insurance
  • Specialized Insurance
  • Insurance Tips & Guides
Insure GenZInsure GenZ
Home»Insurance Tips & Guides»Viatris Settles Lawsuit Over Use of Maryland Woman’s Cells in Drug Research
Insurance Tips & Guides

Viatris Settles Lawsuit Over Use of Maryland Woman’s Cells in Drug Research

AwaisBy AwaisMarch 13, 2026No Comments2 Mins Read1 Views
Facebook Twitter Pinterest Telegram LinkedIn Tumblr Copy Link Email
Follow Us
Google News Flipboard
Detroit-Area Taco Bell Operators Settle Sexual Harassment Lawsuit
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link

Generic drugmaker Viatris has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose tissue samples were used without her permission to develop enduring cells for lucrative medical research.

Viatris and Lacks’ estate told a federal court in Baltimore, Maryland, on Wednesday that they would dismiss the case with prejudice, which means it cannot be refiled.

An attorney for Lacks’ estate said her family was “pleased the parties were able to find a way to resolve this matter” and that details of the settlement were confidential. Spokespeople for Viatris did not immediately respond to a request for comment and more information.

Lacks’ family has filed several lawsuits seeking to recover profits from the unauthorized use of her cells for drug research. Her estate settled a related lawsuit against Novartis in February, resolved another case against Thermo Fisher in 2023 and filed a similar lawsuit against Ultragenyx that is still ongoing.

Novartis Settles Lawsuit by Lacks’ Estate Over ‘Stolen’ Cells

Thermo Fisher Settles with Family for Taking Woman’s Cells 70 Years Ago

Lacks, a Black woman whose story was told in the best-selling book “The Immortal Life of Henrietta Lacks,” sought treatment for cervical cancer in 1951 at a Baltimore hospital. She died of cancer later that year at age 31.

Doctors used a sample of her tumor without her knowledge or consent to cultivate the HeLa cell line. The cells were the first to survive and reproduce indefinitely in lab conditions, and have since been used in worldwide medical research on subjects ranging from the polio vaccine to HIV treatments to sunscreen.

The estate’s 2024 lawsuit accused Canonsburg, Pennsylvania-based Viatris of misusing her cells to test its herpes drug Denavir and depression treatment Mylan-Mirtazapine. The family requested the company’s profits from commercializing the HeLa line and a court order blocking Viatris from using the cells without its permission.

Viatris did not respond to the allegations in court.

(Reporting by Blake Brittain in Washington; Editing by David Bario and Mark Porter)

Topics
Lawsuits
Maryland

Was this article valuable?


Here are more articles you may enjoy.

Interested in Drugs?

Get automatic alerts for this topic.

Cells drug Lawsuit Maryland Research Settles Viatris Womans
Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Telegram Email Copy Link
Awais
  • Website

Related Posts

Poll: Public Worries About Prescription Drug Costs Reach New High; Most Across Political Parties Want Government to Do More to Regulate Prices

March 13, 2026

Housse Heads Facultative for Gallagher; Coggiola to SC Work Comp Board

March 13, 2026

Kentucky Launches $5 Million Roof Grant Program

March 13, 2026
Leave A Reply Cancel Reply

Our Latest Blogs

Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms

March 14, 2026

Inszone absorbs Salt Lake City agency in latest Utah expansion

March 13, 2026

Genetic tests come under scrutiny in Trump administration’s fraud crackdown

March 13, 2026

Muni Bonds in California Get Expensive Amid Flurry of Demand

March 13, 2026
Recent Posts
  • Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms
  • Inszone absorbs Salt Lake City agency in latest Utah expansion
  • Genetic tests come under scrutiny in Trump administration’s fraud crackdown
  • Muni Bonds in California Get Expensive Amid Flurry of Demand
  • Poll: Public Worries About Prescription Drug Costs Reach New High; Most Across Political Parties Want Government to Do More to Regulate Prices

Subscribe to Updates

Insure Genz is a modern insurance blog built for the next generation. Subscribe it for more updates.

Insure Genz is a modern insurance blog built for the next generation. We break down complex topics across categories like Auto, Health, Business, Life, and Travel Insurance — making them simple, useful, and easy to understand. Whether you're just getting started or looking for expert tips and guides, we've got you covered with clear, reliable content.

Our Picks

Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms

March 14, 2026

Inszone absorbs Salt Lake City agency in latest Utah expansion

March 13, 2026

Genetic tests come under scrutiny in Trump administration’s fraud crackdown

March 13, 2026

Muni Bonds in California Get Expensive Amid Flurry of Demand

March 13, 2026
Most Popular

Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms

March 14, 2026

Inszone absorbs Salt Lake City agency in latest Utah expansion

March 13, 2026

Genetic tests come under scrutiny in Trump administration’s fraud crackdown

March 13, 2026

Muni Bonds in California Get Expensive Amid Flurry of Demand

March 13, 2026
  • About Us
  • Contact Us
  • Disclaimer
  • Terms & Conditions
  • Privacy Policy
© 2026 Insure GenZ. Designed by Insure GenZ.

Type above and press Enter to search. Press Esc to cancel.